3rd Quarter - Report
THE MCMANUS GROUP for GENENTECH
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA approval and enforcement issues. 340B payment and implementation issues.
Foreign entity interest: 100% ownership by Roche Holding Ltd., 4070 Basel, Switzerland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Medicare/Medicaid MMM
Medicare coverage and payment of Part B drugs and biologicals. Support for H.R.452 "Medicare Decisions Accountability Act of 2011" and S.668 "Health Care Bureaucrats Elimination Act."
Foreign entity interest: 100% ownership by Roche Holding Ltd., 4070 Basel, Switzerland.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| NICK SHIPLEY | Legislative Director, Rep. Jay Inslee |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.